Literature DB >> 17034611

Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model.

Yuanyuan Zhang1, Dominic Frimberger, Earl Y Cheng, Hsueh-Kung Lin, Bradley P Kropp.   

Abstract

OBJECTIVE: To evaluate small intestinal submucosa (SIS), unseeded or seeded, as a possible augmentation material in a canine model of subtotal cystectomy.
MATERIALS AND METHODS: In all, 22 male dogs had a 90% partial cystectomy and were then divided into three groups. At 1 month after the initial cystectomy, dogs in group 1 (unseeded, six) and group 2 (seeded, six) received a bladder augmentation with a corresponding SIS graft. The dogs in group 3 (ten) received no further surgery and were considered the surgical control group. All dogs were evaluated before and after surgery with blood chemistry, urine culture, intravenous urography, cystograms and cystometrograms. After surgery (at 1, 5 and 9 months), the bladders were examined using routine histology and immunohistochemistry.
RESULTS: All 22 dogs survived the subtotal cystectomy, and 18 survived their intended survival period. One dog, in group 2 (seeded), was killed at 1 month after augmentation due to bladder perforation caused by a large piece of incompletely absorbed SIS. Three other dogs (group 1, two; and group 2, one) were killed within 2 months after augmentation due to bladder obstruction by stones. Group 1 and group 2 SIS grafts had moderate to heavy adhesion, graft shrinkage, and some had bone and calcification at the graft site. Histologically, there was limited bladder regeneration in both groups. Interestingly, dogs in group 3 at 1 month after cystectomy (when group 1 and 2 received their augmentations) had severely shrunken bladders and histologically had severe inflammation, fibroblast infiltration and muscle hypertrophy. These results verify the subtotal cystectomy model.
CONCLUSIONS: The use of seeded or unseeded SIS in a subtotal cystectomy model does not induce the same quality and quantity of bladder regeneration that is seen in the 40% non-inflammatory cystectomy model. This study provides important insights into the process of regeneration in a severely damaged bladder. The results led us to re-evaluate the critical elements required for a complete bladder replacement using tissue-engineering techniques.

Entities:  

Mesh:

Year:  2006        PMID: 17034611     DOI: 10.1111/j.1464-410X.2006.06447.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  44 in total

1.  Bone marrow stem cells for urologic tissue engineering.

Authors:  Dave Shukla; Geoffrey N Box; Robert A Edwards; Darren R Tyson
Journal:  World J Urol       Date:  2008-07-25       Impact factor: 4.226

2.  Generating elastin-rich small intestinal submucosa-based smooth muscle constructs utilizing exogenous growth factors and cyclic mechanical stimulation.

Authors:  Rebecca Long Heise; Julia Ivanova; Aron Parekh; Michael S Sacks
Journal:  Tissue Eng Part A       Date:  2009-12       Impact factor: 3.845

3.  Tissue engineering in urology.

Authors:  Derek J Matoka; Earl Y Cheng
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

Review 4.  Update on tissue engineering in pediatric urology.

Authors:  Blake W Palmer; Bradley P Kropp
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

5.  Electrospun PLLA nanofiber scaffolds for bladder smooth muscle reconstruction.

Authors:  Mohammad Ali Derakhshan; Gholamreza Pourmand; Jafar Ai; Hossein Ghanbari; Rassoul Dinarvand; Mohammad Naji; Reza Faridi-Majidi
Journal:  Int Urol Nephrol       Date:  2016-04-05       Impact factor: 2.370

6.  Engineered tendon with decellularized xenotendon slices and bone marrow stromal cells: an in vivo animal study.

Authors:  Hiromichi Omae; Yu Long Sun; Kai-Nan An; Peter C Amadio; Chunfeng Zhao
Journal:  J Tissue Eng Regen Med       Date:  2011-03-30       Impact factor: 3.963

Review 7.  Bladder biomechanics and the use of scaffolds for regenerative medicine in the urinary bladder.

Authors:  Fatemeh Ajalloueian; Greg Lemon; Jöns Hilborn; Ioannis S Chronakis; Magdalena Fossum
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

8.  Tetronic(®)-based composite hydrogel scaffolds seeded with rat bladder smooth muscle cells for urinary bladder tissue engineering applications.

Authors:  Srikanth Sivaraman; Rachel Ostendorff; Benjamin Fleishman; Jiro Nagatomi
Journal:  J Biomater Sci Polym Ed       Date:  2014-12-13       Impact factor: 3.517

Review 9.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

10.  Bladder augmentation: Review of the literature and recent advances.

Authors:  Serhat Gurocak; Jody Nuininga; Iyimser Ure; Robert P E De Gier; Mustafa Ozgur Tan; Wouter Feitz
Journal:  Indian J Urol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.